PharmD Info

A forum for Indian Pharmacy Professionals

Discuss various Doctor of Pharmacy Knowledge based topics
  • User avatar
#668
JHL Biotech's current capital value is $1.89 billion in New Taiwan dollars. The Taiwan Emerging Stock Board (ESB) is an introductory listing for companies before listing on Taipei Exchange (TPEx) or the Taiwan Stock Exchange (TWSE).

JHL Biotech's public offering is made by certain shareholders selling a portion of their current holdings of JHL Biotech's common stock. Yuanta Securities is the lead underwriter. Investors can contact JHL Biotech or buy directly from the Taiwan Emerging Stock Board.

http://www.prnewswire.co.in/news-releases/jhl-biotech-lists-on-the-taiwan-emerging-stock-board-530424031.html

Tags

A minimum of 60 % score with course completion cer[…]

The Indian Pharmacopoeia Commission, Sector-23, Ra[…]

Biostatistics and Research Methodology - Study Mat[…]

This particular checklist may help your resume to […]

WELCOME TO OUR E-LEARN COURSE WORK MODULES